Literature DB >> 6699138

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes.

M Reichlin, P J Maddison, I Targoff, T Bunch, F Arnett, G Sharp, E Treadwell, E M Tan.   

Abstract

A precipitating antigen-antibody system has been characterized that occurs in patients with polymyositis. At least half of the patients not only have polymyositis but also have scleroderma. The proposed name for this antigen found in calf thymus extract (CTE) is PM-Scl, to indicate the almost universal presence of polymyositis and the frequent occurrence of scleroderma in the patients who make antibodies to this antigen. The antigen is probably nucleolar since all sera which precipitate with the PM-Scl antigen stain the nucleoli of Hep2 cells by indirect immunofluorescence. The PM-Scl immune system is a distinctive one different from the other known precipitins that occur in patients with polymyositis and dermatomyositis including Jo1, nRNP, and Mi. This PM-Scl antigen and its antibody represent one system which constitutes part of the reactions previously designated as PM1. Interlaboratory exchange of sera and extracts have established the unique nature of this reaction which occurs in patients with inflammatory myopathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699138     DOI: 10.1007/bf00915286

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  8 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Description of a serological reaction characteristic of polymyositis.

Authors:  M Reichlin; M Mattioli
Journal:  Clin Immunol Immunopathol       Date:  1976-01

3.  Purification and characterization of a nuclear non-histone basic protein (Mi-1) which reacts with anti-immunoglobulin sera and the sera of patients with dermatomyositis.

Authors:  M Nishikai; M Reichlin
Journal:  Mol Immunol       Date:  1980-09       Impact factor: 4.407

4.  Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

Authors:  M Nishikai; M Reichlin
Journal:  Arthritis Rheum       Date:  1980-08

5.  Antinuclear antibody with distinct specificity for polymyositis.

Authors:  J F Wolfe; E Adelstein; G C Sharp
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

Authors:  T Mimori; M Akizuki; H Yamagata; S Inada; S Yoshida; M Homma
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

8.  Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma.

Authors:  P J Venables; P A Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

  8 in total
  32 in total

Review 1.  Autoantibodies and overlap syndromes in autoimmune rheumatic disease.

Authors:  E C Jury; D D'Cruz; W J Morrow
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  Prevalence in myositis of antibodies recognizing anti-U3 RNA probably in a novel complex with 22/25 kD protein and not fibrillarin.

Authors:  M Kubo; H Ihn; M Kuwana; K Yamane; N Yazawa; K Tamaki
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

3.  Structure of the nuclear exosome component Rrp6p reveals an interplay between the active site and the HRDC domain.

Authors:  Søren F Midtgaard; Jannie Assenholt; Anette Thyssen Jonstrup; Lan B Van; Torben Heick Jensen; Ditlev E Brodersen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

4.  Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen.

Authors:  Q Ge; M B Frank; C O'Brien; I N Targoff
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 5.  Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis.

Authors:  P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 6.  Scleromyositis: a scleroderma/polymyositis overlap syndrome.

Authors:  S Jablonska; M Blaszczyk
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  A nucleolar auto-antigen is part of a major chromosomal surface component.

Authors:  Y Yasuda; G G Maul
Journal:  Chromosoma       Date:  1990-04       Impact factor: 4.316

8.  Identification of protein components reactive with anti-PM/Scl autoantibodies.

Authors:  C Gelpi; A Algueró; M Angeles Martinez; S Vidal; C Juarez; J L Rodriguez-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

9.  Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.

Authors:  I N Targoff; F C Arnett; L Berman; C O'Brien; M Reichlin
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 10.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.